Koen Iterbeke is Chief Strategy Officer (CSO) within the Anacura group, shaping the long-term strategy and growth of its life sciences activities. He has extensive experience in the pharmaceutical industry, including scientific and leadership roles at Johnson & Johnson Innovative Medicine and Pharmacia-Pfizer. Across his career, he has built a strong track record in drug development. Koen serves on the Board of Directors of 4Tissue and Sightera and is an official VUB Fellow aiming to bridge the gap between academia and the biotech industry. He holds a PhD in Sciences (Organic and Peptide Chemistry) from the Free University Brussels (VUB)